Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $215.15 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $79.01 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $64.78 | 5 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $20.23 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $19.14 | 1 | $0 (2024) |
| Alkermes, Inc. | $17.49 | 1 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $14.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.87 | 3 | Teva Pharmaceuticals USA, Inc. ($20.23) |
| 2022 | $26.60 | 2 | Janssen Pharmaceuticals, Inc ($26.60) |
| 2018 | $27.56 | 2 | Janssen Pharmaceuticals, Inc ($27.56) |
| 2017 | $107.12 | 3 | Allergan Inc. ($79.01) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Central Nervous System | ||||||
| 02/01/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Insomnia | ||||||
| 12/16/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Neuroscience | ||||||
| 03/02/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Neuroscience | ||||||
| 03/14/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Neuroscience | ||||||
| 02/02/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Neuroscience | ||||||
| 12/13/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CNS | ||||||
| 12/11/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Neuroscience | ||||||
| 03/01/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $79.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 16 | $5,212 | $2,131 |
| 2022 | 1 | 15 | 82 | $7,790 | $2,462 |
| 2021 | 8 | 212 | 1,311 | $222,823 | $72,645 |
| 2020 | 7 | 221 | 1,104 | $236,390 | $79,646 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 14 | 16 | $5,212 | $2,131 | 40.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 82 | $7,790 | $2,462 | 31.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 730 | $120,030 | $39,812 | 33.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 192 | $44,736 | $14,670 | 32.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 30 | 272 | $25,865 | $8,088 | 31.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 32 | 34 | $8,126 | $2,822 | 34.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 28 | $8,682 | $2,659 | 30.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 17 | $7,718 | $2,294 | 29.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 21 | 24 | $4,488 | $1,351 | 30.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 14 | $3,178 | $948.00 | 29.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 426 | $99,258 | $35,465 | 35.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 100 | 568 | $103,462 | $33,068 | 32.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 29 | 37 | $11,778 | $3,863 | 32.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 23 | $10,442 | $3,690 | 35.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 19 | 23 | $4,373 | $1,345 | 30.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 14 | 15 | $3,673 | $1,283 | 34.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 12 | $3,404 | $931.58 | 27.4% |
About Dr. Sayed Alamy, MD
Dr. Sayed Alamy, MD is a Psychiatry healthcare provider based in Bradford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487662169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sayed Alamy, MD has received a total of $215.15 in payments from pharmaceutical and medical device companies, with $53.87 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($215.15).
As a Medicare-enrolled provider, Alamy has provided services to 462 Medicare beneficiaries, totaling 2,513 services with total Medicare billing of $156,884. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Bradford, PA
- Active Since 08/04/2006
- Last Updated 01/15/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1487662169
Products in Payments
- VRAYLAR (Drug) $79.01
- INVEGA SUSTENNA (Drug) $64.78
- Austedo XR (Drug) $20.23
- COBENFY (Drug) $19.14
- Aristada 441 mg (Drug) $17.49
- QUVIVIQ (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.